Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |